Supporting Community Health and Culturally-Relevant Care
7 Ways Maxor is Helping Whitman-Walker Health Whitman-Walker Health, which provides community-based health and wellness services at multiple locations throughout
Industry News, Maxor, Maxor Pharmacy Management, Maxor340B
How Community of Hope, a Maxor Managed Pharmacy, integrates behavioral support in pharmacy care
by Damon M. Gilliam, PharmD At Community of Hope, the integration of behavioral support starts with establishing a positive relationship
Blog
7 Steps for overcoming 340B ESP and other pricing restrictions
Post Outline 1)Â Our process for recovering savings lost to 340B ESP Introduction / Overview Brief history of 340B-related manufacturer restrictions
340B ESP Terms of Use Set Tone for Demands on Covered Entities
What does it mean for 340B entities? As we noted in a previous post, 340B ESP requires reporting from hospitals submitting
340B, Blog
340B ESP: Why it’s wrong and how hospitals can deal with it
Post Outline 1)Â Introduction / Overview 2)Â What is the 340B Drug Pricing Program? 3)Â A brief history of 340B ESP The reporting
340B, Blog
How Meds to Beds programs improve outpatient medication compliance
Overview As we reported in our post on Value-Based Care, statistical evidence indicates that up to 70% of all preventable hospital readmissions
340B, Blog
Best practices every 340B hospital needs to know
Post Outline 1) Introduction Overview: Savings potential of a 340B program. 340B savings generated by VytlOne ($300M in 2025 alone. 2) Tips
How and Why TPAs Misqualify 340B-Eligible Prescriptions
PLEASE NOTE:This article should not be construed as an attack on TPAs. VytlOne has managed 340B programs for dozens of hospitals, and
340B, Blog
How can you ensure 340B compliance and avoid non-compliance
Post Outline 1)Â Getting started with the 340B Program Are you 340B eligible? 340B Eligibility resource. 2)Â Maintaining 340B Program Compliance Why
340B, Blog
What is the 340B drug pricing program?
Overview The 340B drug pricing program was created by Congress in 1992 to provide significant discounts on prescription drugs for certain health